Literature DB >> 23019305

Molecular pathways: the metabolic regulator estrogen-related receptor α as a therapeutic target in cancer.

Ching-yi Chang1, Donald P McDonnell.   

Abstract

The estrogen-related receptor α (ERRα) is an orphan member of the nuclear receptor superfamily of transcription factors whose activity is regulated by the expression level and/or activity of its obligate coregulators, peroxisome proliferator-activated receptor γ coactivator-1 α and β (PGC-1α or PGC-1β). Under normal physiologic conditions, and in responding to different environmental stimuli, the ERRα/PGC-1 complex is involved in regulating metabolic homeostasis under conditions of high energy demand in brown adipocytes, proliferating T cells, and muscle. Interestingly, increased expression and activity of the ERRα/PGC-1 axis has also been shown to correlate with unfavorable clinical outcomes in both breast and ovarian tumors. The observation that ERRα activity is manifest in all breast tumor subtypes with particularly high activity being evident in ERα-negative, HER2-positive, and triple-negative breast cancers has raised significant interest in targeting this receptor for the treatment of those breast cancers for which therapeutic options are limited. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23019305      PMCID: PMC3500439          DOI: 10.1158/1078-0432.CCR-11-3221

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  58 in total

Review 1.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

2.  Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription coactivator associated with host cell factor.

Authors:  Jiandie Lin; Pere Puigserver; Jerry Donovan; Paul Tarr; Bruce M Spiegelman
Journal:  J Biol Chem       Date:  2001-11-30       Impact factor: 5.157

3.  Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis.

Authors:  Geneviève Deblois; Ghada Chahrour; Marie-Claude Perry; Guillaume Sylvain-Drolet; William J Muller; Vincent Giguère
Journal:  Cancer Res       Date:  2010-10-20       Impact factor: 12.701

4.  Protein kinase C epsilon affects mitochondrial function through estrogen-related receptor alpha.

Authors:  Na Lu; Wenxian Wang; Jinsong Liu; Chi-Wai Wong
Journal:  Cell Signal       Date:  2011-05-09       Impact factor: 4.315

5.  ATP citrate lyase inhibition can suppress tumor cell growth.

Authors:  Georgia Hatzivassiliou; Fangping Zhao; Daniel E Bauer; Charalambos Andreadis; Anthony N Shaw; Dashyant Dhanak; Sunil R Hingorani; David A Tuveson; Craig B Thompson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

6.  Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.

Authors:  Joerg Kallen; Jean-Marc Schlaeppi; Francis Bitsch; Ireos Filipuzzi; Alain Schilb; Virginie Riou; Alexander Graham; Andre Strauss; Martin Geiser; Brigitte Fournier
Journal:  J Biol Chem       Date:  2004-08-26       Impact factor: 5.157

7.  Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif.

Authors:  Annie M Tremblay; Brian J Wilson; Xiang-Jiao Yang; Vincent Giguère
Journal:  Mol Endocrinol       Date:  2007-12-06

8.  Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.

Authors:  Takashi Suzuki; Yasuhiro Miki; Takuya Moriya; Norihiro Shimada; Takanori Ishida; Hisashi Hirakawa; Noriaki Ohuchi; Hironobu Sasano
Journal:  Cancer Res       Date:  2004-07-01       Impact factor: 12.701

9.  The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha).

Authors:  Sylvia N Schreiber; Darko Knutti; Kathrin Brogli; Thomas Uhlmann; Anastasia Kralli
Journal:  J Biol Chem       Date:  2003-01-08       Impact factor: 5.157

10.  Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense.

Authors:  Junichiro Sonoda; Josée Laganière; Isaac R Mehl; Grant D Barish; Ling-Wa Chong; Xiangli Li; Immo E Scheffler; Dennis C Mock; Alain R Bataille; Francois Robert; Chih-Hao Lee; Vincent Giguère; Ronald M Evans
Journal:  Genes Dev       Date:  2007-08-01       Impact factor: 11.361

View more
  31 in total

1.  Estrogen Receptors alpha and beta in Ovarian Cancer: Expression Level and Prognosis.

Authors:  T A Bogush; A A Basharina; E A Bogush; O M Ryabinina; A S Tjulandina; S A Tjulandin
Journal:  Dokl Biochem Biophys       Date:  2018-11-05       Impact factor: 0.788

2.  Development of a stable cell line with an intact PGC-1α/ERRα axis for screening environmental chemicals.

Authors:  Christina T Teng; Burton Beames; B Alex Merrick; Negin Martin; Charles Romeo; Anton M Jetten
Journal:  Biochem Biophys Res Commun       Date:  2014-01-20       Impact factor: 3.575

Review 3.  The estrogen-related receptors (ERRs): potential targets against bone loss.

Authors:  Ling Zhang; Jiemin Wong; Jean-Marc Vanacker
Journal:  Cell Mol Life Sci       Date:  2016-08-11       Impact factor: 9.261

4.  Complementary Roles of Estrogen-Related Receptors in Brown Adipocyte Thermogenic Function.

Authors:  Marin L Gantner; Bethany C Hazen; Elodie Eury; Erin L Brown; Anastasia Kralli
Journal:  Endocrinology       Date:  2016-10-20       Impact factor: 4.736

5.  Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation.

Authors:  Lijie Peng; Zhensheng Zhang; Chong Lei; Shan Li; Zhang Zhang; Xiaomei Ren; Yu Chang; Yan Zhang; Yong Xu; Ke Ding
Journal:  ACS Med Chem Lett       Date:  2019-04-12       Impact factor: 4.345

6.  Identification of Estrogen-Related Receptor α Agonists in the Tox21 Compound Library.

Authors:  Caitlin Lynch; Jinghua Zhao; Ruili Huang; Noriko Kanaya; Lauren Bernal; Jui-Hua Hsieh; Scott S Auerbach; Kristine L Witt; B Alex Merrick; Shiuan Chen; Christina T Teng; Menghang Xia
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

Review 7.  The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.

Authors:  Jianrong Lu; Ming Tan; Qingsong Cai
Journal:  Cancer Lett       Date:  2014-04-13       Impact factor: 8.679

8.  Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice.

Authors:  Linette Castillo-Pichardo; Luis A Cubano; Suranganie Dharmawardhane
Journal:  BMC Complement Altern Med       Date:  2013-01-08       Impact factor: 3.659

Review 9.  Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?

Authors:  Wen Zhang; Shao-Lin Zhang; Xiaohui Hu; Kin Yip Tam
Journal:  Int J Biol Sci       Date:  2015-11-01       Impact factor: 6.580

10.  Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway.

Authors:  Faegheh Ghanbari; Anne-Marie Fortier; Morag Park; Anie Philip
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.